As of Mar 27
| +0.32 / +1.08%|
The 3 analysts offering 12-month price forecasts for Medifast Inc have a median target of 33.00, with a high estimate of 33.00 and a low estimate of 32.00. The median estimate represents a +10.15% increase from the last price of 29.96.
The current consensus among 3 polled investment analysts is to Hold stock in Medifast Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.